Editorial Board — Medscape Pulmonary Medicine

Board Members

 

Board Member Details

James F. Donohue, MD
James F. Donohue, MD

Professor, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina

James F. Donohue, MD, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Boehringer Ingelheim Pharmaceuticals, Inc.; Centeon Pharma; Pfizer Inc.
Served as a advisor for: Boehringer Ingelheim Pharmaceuticals, Inc.; Forest Laboratories, Inc.; GlaxoSmithKline; Pfizer Inc.

[ Back to Top ]
Christopher J. Lettieri, MD
Christopher J. Lettieri, MD

Associate Professor of Medicine, Uniformed Services University, Bethesda, Maryland; Chief of Pulmonary, Critical Care and Sleep Medicine, Walter Reed Army Medical Center, Washington, DC

Christopher J. Lettieri, MD, has disclosed no relevant financial relationships.

[ Back to Top ]
Steven Nathan, MD
Steven Nathan, MD

Associate Professor, Virginia Commonwealth University, Richmond, Virginia; Medical Director, Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia

Steven Nathan, MD, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Actelion Pharmaceuticals, Ltd.; Gilead Sciences, Inc.; InterMune, Inc.; United Therapeutics Corporation
Served as a speaker or member of a speakers bureau for: Actelion Pharmaceuticals, Ltd.; Gilead Sciences, Inc.; United Therapeutics Corporation
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Actelion Pharmaceuticals, Ltd.; Bayer HealthCare Pharmaceuticals; GeNO LLC; Gilead Sciences, Inc.; InterMune, Inc.; Pfizer Inc.; United Therapeutics Corporation
Received income in an amount equal to or greater than $250 from: Actelion Pharmaceuticals, Ltd.; Bayer HealthCare Pharmaceuticals; GeNO LLC; Gilead Sciences, Inc.; InterMune, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; United Therapeutics Corporation

[ Back to Top ]
Michael S. Niederman, MD
Michael S. Niederman, MD

Professor of Medicine, SUNY at Stony Brook, Stony Brook, New York; Chairman, Department of Medicine, Winthrop-University Hospital, Mineola, New York

Michael S. Niederman, MD, has disclosed the following relevant financial relationships:
Served as a speaker or member of a speakers bureau for: Merck & Co., Inc.; Pfizer Inc.
Received income in an amount equal to or greater than $250 from: Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.

[ Back to Top ]
Andrew F. Shorr, MD, MPH
Andrew F. Shorr, MD, MPH

Associate Professor of Medicine, Georgetown University; Associate Director of Pulmonary and Critical Care Medicine, Washington Hospital Center, Washington, DC

Andrew F. Shorr, MD, MPH, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Astellas Pharma, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Covidien; Pfizer Inc.
Served as a speaker or a member of a speakers bureau for: Astellas Pharma, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Covidien; Pfizer Inc.
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Astellas Pharma, Inc.; AstraZeneca Pharmaceuticals, LP; Bayer HealthCare Pharmaceuticals; Canyon Pharmaceuticals, Inc.; C.R. Bard, Inc.; Eisai Inc.; Eli Lilly and Company; Forrest Laboratories Inc.; Theravance
Received income in an amount equal to or greater than $250 from: Astellas Pharma, Inc.; AstraZeneca Pharmaceuticals, LP; Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Canyon Pharmaceuticals, Inc.; Covidien; C.R. Bard, Inc.; Eisai Inc.; Eli Lilly and Company; Forrest Laboratories Inc.; Pfizer Inc.; Theravance

[ Back to Top ]
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.